Klepsch, V., Hermann-Kleiter, N., Do-Dinh, P., Jakic, B., Offermann, A., Efremova, M., . . . Baier, G. (2018). Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade. Nature communications, 9(1), 1538-13. https://doi.org/10.1038/s41467-018-04004-2
Citace podle Chicago (17th ed.)Klepsch, Victoria, et al. "Nuclear Receptor NR2F6 Inhibition Potentiates Responses to PD-L1/PD-1 Cancer Immune Checkpoint Blockade." Nature Communications 9, no. 1 (2018): 1538-13. https://doi.org/10.1038/s41467-018-04004-2.
Citace podle MLA (9th ed.)Klepsch, Victoria, et al. "Nuclear Receptor NR2F6 Inhibition Potentiates Responses to PD-L1/PD-1 Cancer Immune Checkpoint Blockade." Nature Communications, vol. 9, no. 1, 2018, pp. 1538-13, https://doi.org/10.1038/s41467-018-04004-2.